Dr. Akerman leads Akerman Laboratories’ translational research program in cardiovascular diagnostics, disease mechanisms, and therapeutic development. His work integrates molecular biology, preclinical models, clinical biorepositories, and data-driven analytics to improve detection and treatment of complex cardiovascular disease.

Kyle Alexander leads research operations, regulatory coordination, scientific writing, data stewardship, and analytics. He supports protocol development, IRB/IACUC activities, manuscript preparation, project tracking, and reproducible research workflows.

Elizabeth Collins oversees laboratory operations, compliance, animal studies, advanced assays, equipment maintenance, and technical workflows. Her work supports the rigor, safety, and reproducibility of the laboratory’s translational research programs.